LESAKA TECHNOLOGIES, INC.
Unaudited Condensed Consolidated Statements of Cash Flows
9
Three months ended
Nine months ended
March 31,
March 31,
2026
2025
2026
2025
(In thousands)
(In thousands)
Cash flows from operating activities
Net income (loss)
(A)
$
437
$
(22,333)
$
(707)
$
(59,611)
Depreciation and amortization
10,543
8,429
37,005
22,928
Impairment loss
2,604
-
2,604
-
Movement in allowance for doubtful accounts receivable
2,502
1,679
9,311
5,699
Fair value adjustment related to financial liabilities
(197)
105
(162)
(159)
Loss on disposal of equity securities (Note 6)
-
-
730
-
Loss on disposal of equity-accounted investments (Note 6)
-
-
584
161
Earnings from equity-accounted investments
(56)
(12)
(166)
(89)
Reversal of allowance for doubtful loans receivable
(1,500)
-
(1,500)
-
Gain on deconsolidation of subsidiary
(848)
-
(848)
-
Change in fair value of equity securities (Note 5 and 6)
378
20,421
(2,593)
54,152
Other income
-
-
(3,883)
-
Profit on disposal of property, plant and equipment
(188)
(12)
(245)
(53)
Movement in interest payable
83
2,886
(85)
6,443
Facility fee amortized
92
83
258
220
Stock-based compensation charge (Note 13)
1,334
2,497
5,140
7,518
Dividends received from equity-accounted investments
105
-
105
65
Decrease (Increase) in accounts receivable
12,613
10,820
(69)
6,525
Increase in finance loans receivable
(535)
(11,819)
(30,116)
(21,734)
Decrease in inventory
7,393
9,415
8,592
3,966
Increase (Decrease) in accounts payable and other payables
(A)
2,141
(9,208)
14,763
(17,620)
Deferred consideration due to seller of Recharger included in accounts payable
and other payables (Note 2 and Note 10)
-
1,130
-
1,130
Increase in taxes payable
1,254
1,012
1,344
1,624
Decrease in deferred taxes
(585)
(4,430)
(4,485)
(13,804)
Net cash provided by (used in) operating activities
37,570
10,663
35,577
(2,639)
Cash flows from investing activities
Capital expenditures
(3,398)
(2,817)
(11,300)
(13,100)
Proceeds from disposal of property, plant and equipment
(671)
395
240
1,720
Acquisition of intangible assets
(1,205)
(1,673)
(3,352)
(2,274)
Acquisitions, net of cash acquired
(10,772)
(8,997)
(11,117)
(12,954)
Cash disposed on disposal of subsidiary
-
-
(165)
-
Investment in equity securities
-
-
(250)
-
Proceeds from disposal of equity securities (Note 6)
-
-
2,971
-
Net change in settlement assets
6,295
3,085
7,049
5,389
Net cash used in investing activities
(9,751)
(10,007)
(15,924)
(21,219)
Cash flows from financing activities
Proceeds from bank overdraft (Note 9)
44,908
21,440
93,417
94,188
Repayment of bank overdraft (Note 9)
(29,376)
(50,458)
(82,477)
(85,998)
Long-term borrowings utilized (Note 9)
706
175,819
4,735
189,496
Repayment of long-term borrowings (Note 9)
(10,203)
(134,503)
(12,588)
(148,297)
Acquisition of non-controlling interest
(3,538)
-
(3,538)
-
Acquisition of treasury stock (Note 13)
(40)
(27)
(311)
(12,613)
Proceeds from exercise of stock options
-
59
-
110
Guarantee fee
-
(539)
(33)
(970)
Dividends paid to non-controlling interest
-
(131)
-
(432)
Net change in settlement obligations
(5,959)
(3,152)
(6,436)
(5,591)
Net cash (used in) provided by financing activities
(3,502)
8,508
(7,231)
29,893
Effect of exchange rate changes on cash and cash equivalents
(3,221)
1,222
1,636
(830)
Net increase in cash, cash equivalents and restricted cash
21,096
10,386
14,058
5,205
Cash, cash equivalents and restricted cash – beginning of period
69,601
60,737
76,639
65,918
Cash, cash equivalents and restricted cash – end of period (Note 15)
$
90,697
$
71,123
$
90,697
$
71,123
(A) Revised to correct the errors discussed in Note 1.
See Notes to Unaudited Condensed Consolidated Financial Statements